Latest filing published 04 Mar 2026 for 온코닉테라퓨틱스, €7.6M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
제일약품 appears in our data through filings on 온코닉테라퓨틱스 shares, published by DART (FSS). Over a trading history stretching from 19 December 2024 to 24 February 2026, the count stands at 6 filings.
The open-market side counts 5 purchases alongside 1 sale for €7.6M. No amount is published for 5 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 2 purchases and 1 sale.
The newest entry dates from 4 March 2026: an open-market sale of €7.6M, in 온코닉테라퓨틱스. The clock since the last published purchase (12 January 2026) now reads 286 days. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations